LifeWealth Investments’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$277K Sell
552
-2
-0.4% -$960 0.07% 112
2026
Q1
$272K Sell
554
-17
-3% -$9.23K 0.08% 115
2025
Q4
$331K Sell
571
-545
-49% -$308K 0.1% 113
2025
Q3
$541K Buy
1,116
+3
+0.3% +$1.4K 0.08% 133
2025
Q2
$451K Buy
+1,113
New +$465K 0.08% 166

Other funds holding TMO

LifeWealth Investments's TMO Position: Q2 2026 in Review

LifeWealth Investments reduced its Thermo Fisher Scientific (TMO) stake by 0.36% in Q2 2026, selling an estimated $960 and leaving 552 shares worth $277K. The position accounts for 0.07% of the portfolio, ranked #112.

LifeWealth Investments first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. The position peaked at $541K in Q3 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • LifeWealth Investments held 552 shares of Thermo Fisher Scientific worth $277K as of Q2 2026.
  • LifeWealth Investments sold 2 Thermo Fisher Scientific shares in Q2 2026, an estimated $960.
  • Thermo Fisher Scientific made up 0.07% of LifeWealth Investments's portfolio in Q2 2026, its #112 holding.
  • LifeWealth Investments first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • LifeWealth Investments's Thermo Fisher Scientific position peaked at $541K in Q3 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on LifeWealth Investments's 13F filing for Q2 2026, filed 16 Jul 2026.